Sanders v. DJO, LLC

728 F. Supp. 2d 1200, 2010 U.S. Dist. LEXIS 89652, 2010 WL 3033551
CourtDistrict Court, D. New Mexico
DecidedJuly 7, 2010
DocketCIV 09-1092 BB/ACT
StatusPublished
Cited by1 cases

This text of 728 F. Supp. 2d 1200 (Sanders v. DJO, LLC) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sanders v. DJO, LLC, 728 F. Supp. 2d 1200, 2010 U.S. Dist. LEXIS 89652, 2010 WL 3033551 (D.N.M. 2010).

Opinion

MEMORANDUM OPINION

BRUCE D. BLACK, District Judge.

This matter comes before the Court for consideration of a motion to remand filed by Plaintiff (Doc. 25). The Court has reviewed the submissions of the parties and the relevant law. Based on this review, the motion to remand will be granted.

Facts

Plaintiff filed suit in state court raising products liability and negligence claims against all Defendants. According to Plaintiff, she underwent shoulder surgery and as part of the surgery a “pain pump” was implanted into her shoulder, which injected pain medication at the site of the surgery. The “pain pump” allegedly became toxic and caused Plaintiff severe injuries, for which she seeks compensation. Defendants removed Plaintiffs’ lawsuit to federal court, maintaining the parties are diverse and none of the properly-named Defendants are citizens of New Mexico. Defendants acknowledged in their removal petition that one Defendant, Lovelace Health Systems (“Lovelace”), is a citizen of New Mexico. However, Defendants argued that Lovelace was fraudulently joined as a defendant, and therefore Lovelace’s citizenship should be ignored when analyzing the diversity of the parties. Subsequently, Plaintiff moved to remand the action to state court, disputing Defendants’ contentions regarding the joinder of Lovelace as a Defendant. The dispositive question before the Court, therefore, is whether Lovelace is a proper Defendant whose presence in this lawsuit destroys diversity. If so, the case must be remanded.

Standard of Review

Defendants claiming that fraudulent joinder has occurred bear the burden of establishing that fact. This burden is a heavy one. See, e.g., Schur v. L.A. Weight Loss Centers, Inc., 577 F.3d 752, 764 (7th Cir.2009); Montano v. Allstate Indemnity, 2000 WL 525592 (10th Cir.unpublished). If there is any reasonable possibility the plaintiff could prevail on any claim against the non-diverse defendant, the joinder is not fraudulent and the case must be remanded. 1 See Schur; Montano. In examining the fraudulent-joinder issue, the Court is not limited to the pleadings filed by the parties but may pierce those pleadings and consider the entire record of the case as well as any evidence the parties may choose to submit. See Smoot v. Chicago, R.I. & P.R. Co., 378 F.2d 879, 882 *1203 (10th Cir.1967); see also Badon v. R J R Nabisco Inc., 224 F.3d 382, 393 (5th Cir.2000) (relying on affidavits to determine fraudulent-joinder issue, and discussing similarity to summary-judgment process).

It must be noted that the “reasonable possibility” standard is not the same as the failure-to-state-a-claim standard that is applicable under Rule 12(b)(6) of the Federal Rules of Civil Procedure. Instead, the Court must look at the facts present in the case, not simply those alleged in the complaint, and determine whether there is a reasonable possibility that those facts, construed in the light most favorable to the plaintiff, could result in a viable claim against the non-diverse defendant. This standard is more deferential to the plaintiffs alleged claim than is the Rule 12(b)(6) standard. See Schur, supra, 577 F.3d at 764 (citing several cases stating that burden for plaintiff is even more favorable than the motion-to-dismiss standard applied under Rule 12(b)(6)); Hartley v. CSX Transp., Inc., 187 F.3d 422, 424 (4th Cir.1999); Batoff v. State Farm Ins. Co., 977 F.2d 848, 852 (3d Cir. 1992). 2 Under this standard, it is entirely possible a case should be remanded even though the claims brought against the non-diverse defendant will ultimately be subject to dismissal. See Spataro v. Depuy Orthopaedics, Inc., 2009 WL 382617 (D.N.M.unpublished) (where federal court would have to decide issue of first impression under state law to decide whether plaintiffs claim against non-diverse defendant was viable, court remanded case despite possibility that plaintiffs strict-liability claim might be rejected by the state courts); see also Reeser v. NGK Metals Corp., 247 F.Supp.2d 626, 629 (E.D.Pa.2003) (fact that claim against party may ultimately be dismissed does not necessarily mean the party was fraudulently joined); cf. Crowe v. Coleman, 113 F.3d 1536, 1541 (11th Cir.1997) (plaintiff need not show he could defeat summary judgment to gain remand).

Discussion

Fraudulent Joinder on the Merits: Plaintiffs complaint raises two claims against Lovelace — a strict-liability claim based on products liability, and a common-law negligence claim. Defendants maintain neither of these claims has any potential viability.

With respect to the products-liability claim, Defendants argue such a claim is disallowed against a hospital such as Lovelace under New Mexico law and public policy. In support of that argument Defendants cite Parker v. St. Vincent Hospital, 122 N.M. 39, 919 P.2d 1104 (N.M.App.1996), a case in which the New Mexico Court of Appeals did indeed decide that, as a matter of public policy, a products-liability claim should not be allowed against a hospital where an allegedly defective product was implanted into plaintiffs person. Id. p. 1110. At first glance Parker appears to be on all fours with this case, in which an allegedly defective pain pump was implanted into Plaintiffs shoulder. However, Plaintiff does not concede this point. Plaintiff instead points out a limitation contained in the Parker opinion; the Court of Appeals specifically restricted its holding to situations in which the patient’s treating physician, and not the hospital, selected the offending product that was implanted into the patient. Id. pp. 1107, 1110. Plaintiff argues that in this case discovery is necessary to decide whether Lovelace had any role in selecting the pain *1204 pump or otherwise encouraging its use, and that until such discovery is performed the products-liability claim remains viable with respect to Lovelace.

If Parker were the last word on the subject, the Court would most likely agree that the question raised by Plaintiff remains unresolved and should not be decided by a federal court in connection with a removal-and-remand dispute. See Spataro, supra. However, shortly after Parker

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
728 F. Supp. 2d 1200, 2010 U.S. Dist. LEXIS 89652, 2010 WL 3033551, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sanders-v-djo-llc-nmd-2010.